Advertisement

Device-related or foreign-body-related infection is a complication of medical progress, which has progressively increased over the past three decades and will continue to rise for the foreseeable future. We can only hope to limit the rates of infection per device and reduce the consequences from prompt and appropriate management, but absolute prevention will be unattainable. As technological advances in medicine continue to progress, there will be new and innovative devices implanted in patients to prolong and improve the quality of life, and with these new techniques it is predictable that there will be novel infections associated with their implantation.

There are numerous devices inserted in the human body for various conditions, and the scope of this chapter is not to review all foreign-body-related infections, but the most frequent and troublesome conditions. Devices that are most prone to infections are usually meant for temporary use but have become long term or permanent due to special needs. These usually involve catheters communicating with a normally sterile site with the surface of the body, i.e., urethral catheters and intravascular catheters. Table 10.1 lists devices and risk of infection.

Keywords

Central Venous Catheter Infective Endocarditis Bloodstream Infection Left Ventricular Assist Device Graft Infection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Schierholz, J.M., Beuth, J., (2001), Implant infections: A haven for opportunistic bacteria. J. Hosp. Infect. 49: 87–93.PubMedGoogle Scholar
  2. 2.
    Costerton, J.W., Stewart, P.S., Greenberg, E.P., (1999), Bacterial biofilms: A common cause of persistent infections. Science 284: 1318–1322.PubMedGoogle Scholar
  3. 3.
    Donlan, R.M., Costerton, J.W. (2002), Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15:167–193.PubMedGoogle Scholar
  4. 4.
    Costerton, W., Veeh, R., Shirtliff, M., Passmore, M., Post, C., Ehreich, G., (2003), The application of biofilm science to the study and control of chronic bacterial infections. J. Clin. Invest. 112:1466–1477.PubMedGoogle Scholar
  5. 5.
    Davies, D.G., Geesey, G.G., (1995), Regulation of alginate biosynthesis gene algc in Pseudomonas aeruginosa during biofilm development in continuing culture. Appl. Environ. Microbiol. 61:866–867.Google Scholar
  6. 6.
    Suci, P.A., Mittelman, M.W., Yu, F.P., Geesey, G.G., (1994), Investigation of ciprofloxacin penetration into Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 38:2125–2133.PubMedGoogle Scholar
  7. 7.
    Stewart, P.S., (1996), Theoretical aspects of antibiotic diffusion into microbial biofilms. Antimicrob. Agents Chemother. 40:2517–2522.PubMedGoogle Scholar
  8. 8.
    Sauer, K., Camper, A.K., Ehrlich, G.D., Costerton, J.W., Davies, D.G., (2002), Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J. Bacteriol. 184:1140–1154.PubMedGoogle Scholar
  9. 9.
    Wagman, G.H., Bailey, J.V., Weinstein, M.J., (1975), Binding of aminoglycoside antibiotics to filtration materials. J. Antimicrob. Agents Chemother. 7:316–319.Google Scholar
  10. 10.
    Schierholz, J.M., Beuth, J., Pulveren, G., (1999), Adherent bacteria and activity of antibiotics. J. Antimicrob. Chemother. 43:158–160.PubMedGoogle Scholar
  11. 11.
    Kaplan, S.S., Basfort, R.E., Kormos, R.L., (1990), Biomaterial-associated impairment of local neutrophil function. Am. Soc. Artificial Int. Organ Transplant. J. 36: M 172–175.Google Scholar
  12. 12.
    Zimmerli, W., Lew, P.D., Waldvogel, F.A., (1984), Pathogenesis of foreign body infections: evidence of a local granulocyte defect. J. Clin. Invest. 73:1191–1200.PubMedGoogle Scholar
  13. 13.
    Shanbhag, A., Yang, J., Lilien, J., Black, J., (1992), Decreased neutrophils respiratory burst on exposure to cobaltchrome alloy and polysterene in vitro. J. Biomed. Mat. Res. 26:185–195.Google Scholar
  14. 14.
    Zimmerli, W., Waldvogel, F.A., Vaudaux, P., Nydegger, U.F., (1982), Pathogenesis of foreign bosy infection: description and characteristics of an animal model. J. Infect. Dis. 146:187–197.Google Scholar
  15. 15.
    Myrvik, Q.N., Wagner, W., Barth, E., Wood, P., Gristina A.G., (1989), Effects of extracellular slime produced by Staphylococcus epidermidis on oxidative responses of rabbit alveolar macrophages. J. Invest. Surg. 2:381–389.PubMedGoogle Scholar
  16. 16.
    Johnson, G.M., Lee, D.A., Regelmann, W.E., Gray, E.D., Peters, G., Quie, P.G., (1986), Interference with granulocyte function by Staphylococcus epidermidis slime. Infect. Immun. 54:13–20.PubMedGoogle Scholar
  17. 17.
    Modun, B., Williams, P., Pike, N.J., (1992), Cell envelope proteins of S.epidermidis grown in vivo in a peritoneal chamber implant. Infect. Immune. 60:2551–2553.Google Scholar
  18. 18.
    Noble, M.A., Grant, S.K., Hajen, E., (1990), Characterization of a neutrophils inhibitor factor from clinically significant S epidermidis infection. J. Infect. Dis. 162:909–913.PubMedGoogle Scholar
  19. 19.
    Gray, E.D., Verstegen, M., Peters, G., Regelman, W.E., (1984), Effect of extracellular slime substance from Staphylococcus epidermidis on the human cellular response. Lancet 1:365–367.PubMedGoogle Scholar
  20. 20.
    Tang, L., Eaton, J.W., (1995), Inflammatory responses to biomaterials. Am. J. Clin. Pathol. 103:466–471.PubMedGoogle Scholar
  21. 21.
    Henke, P.K., Bergamini, T.M., Garrison, J.R., Brittian, K.R., Peytom, J.C., Lam, T.M., (1997), Staphylococcus epidermidis graft infection is associated with locally suppressed major histocompatibility complex class II and elevated MAC-1 expression. Arch. Surg. 132:894–902.PubMedGoogle Scholar
  22. 22.
    Henke, P.K., Bergamini, T.M., Brittian, K.R., Polk, H.C.Jr., (1997), Prostaglandin E2 modulates monocyte MH-II(Ia) suppression in biomaterial infection. J. Surg. Res. 69:372–378.PubMedGoogle Scholar
  23. 23.
    Ankersmit, H.J., Edwards, N.M., Schuster, M., John, R., Kocher, A., Rose, E.A., Oz, M., Itescu, S., (1999), Quantitative changes in T-cell population after left ventricular assist device implantation: Relationship to T-cell apoptosis and soluble CD95. Circulation 100 (Suppl 19): II211–II215.PubMedGoogle Scholar
  24. 24.
    Rothenburger, M., Wilhelm, M., Hammel, D., Schmid, C., Plenz, G., Tjan, T.D.T, Baba, H., Schlter, B., Scheld, H.H., Deng, M.C., Erren. M., (2001), Immune response in the early postoperative period after implantation of a left-ventricular assist device system. Transplant. Proc. 33: 1955–1957.PubMedGoogle Scholar
  25. 25.
    Itescu, S., Ankersmit, H.J., Kocher, A.A., Schuster, M.D., (2000), Immunobiology of left ventricular assist devices. Prog. Cardiovasc. Dis. 43: 67–80.PubMedGoogle Scholar
  26. 26.
    Sapatnekar, S., Kao, W.J., Anderson, J.M., (1997), Leucocyte-biomaterial interactions in the presence of Staphylococcus epidermidis: Flow cytometric evaluation of leukocyte activation. J. Biomed. Mater. Res. 1535: 409–420.Google Scholar
  27. 27.
    Ceri, H., Olson, M.E., Strenich, C., Read, R.R., Morck, D, Buret, A., (1999), The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibities of bacterial biofilms. J. Clin. Microbiol. 37: 1771–1776.PubMedGoogle Scholar
  28. 28.
    Williams, I., Venables, W.A., Lloyd, D., Paul, F., Critchley, I., (1997), The effects of adherence to silicone surfaces on antibiotic susceptibility in Staphylococcus aureus. Microbiology 143: 2407–2413.PubMedGoogle Scholar
  29. 29.
    Larsen, T., Fiehn, N.E., (1996), Resistance of Streptococcus sanguis biofilms to antimicrobial agents. APMIS 104: 280–284.PubMedGoogle Scholar
  30. 30.
    Vorachit, M., Lam, K, Jayanetra, P., Costerton, J.W., (1993), Resistance of Pseudomonas pseudomallei growing as a biofilm on silastic disks to ceftazidime and cotrimoxazole. Antimicrob. Agents Chemother. 37: 2000–2002.PubMedGoogle Scholar
  31. 31.
    Anderl, J.N., Franklin, M.J., Stewart, P.S., (2000), Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob. Agents Chemother. 44: 1818–1824.PubMedGoogle Scholar
  32. 32.
    Stewart, P.S., Costerton, J.W., (2001), Antibiotic resistance of bacteria in biofilms. Lancet; 358: 135–138.PubMedGoogle Scholar
  33. 33.
    Nichols, W.W., Dorrington, S.M., Slack, M.P.E. Walmsley, H.L., (1988), Inhibition of tobramycin diffusion by binding to alginate. Antimicrob. Agents Chemother. 32: 518–523.PubMedGoogle Scholar
  34. 34.
    Shigeta, M., Tanaka, G., Komatsuzawa, H., Sugai, M., Suginaka, H., Hsui, T., (1997), Permeation of antimicrobial agents through Pseudomonas aeruginosa biofilms: A simple method. Chemotherapy; 43: 340–345.PubMedGoogle Scholar
  35. 35.
    Brooun, A., Liu, S., Lewis, K., (2000), A dose-response study of antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 44: 640–646.PubMedGoogle Scholar
  36. 36.
    de Beer, D., Stoodley, P., Roe, F., Lewandowski, Z., (1994), Effects of biofilm structure on oxygen distribution and mass transport. Biotechnol. Bioeng. 43: 1131 –1138.PubMedGoogle Scholar
  37. 37.
    Zhang, T.C., Bishop, P.L., (1996), Evaluation of substrate and pH effects in a nitrifying biofilm. Wat. Environ. Res. 68: 1107 –1115.Google Scholar
  38. 38.
    Evans, D.J., Allison, D.G., Brown, M.R.W., Gilbert, P., (1990) Effect of growth-rate on resistance of gram-negative biofilms to cetrimide. J. Antimicrob. Chemother. 26: 473 –478.PubMedGoogle Scholar
  39. 39.
    DuGuid. I.G., Evans, E., Brown, M.R.W., Gilbert, P., (1990), Growth-rate-dependent killing by ciprofloxacin of biofilm-derived Staphylococcus epidermidis: Evidence for cell-cycle dependency. J. Antimicrob. Chemother. 30: 791 –802.Google Scholar
  40. 40.
    Anwar, H., Strap, J.L., Chen, K., Costerton, J.W., (1992), Dynamic interactions of biofilms of mucoid Pseudomonas aeruginosa with tobramycin and piperacillin. Antimicrob. Agents Chemother. 36: 1208 –1214.PubMedGoogle Scholar
  41. 41.
    Dagostino, L., Goodman, A.E., Marshall, K.C., (1991), Physiological responses induced in bacteria adhering to surfaces. Biofouling 4: 113 –119.Google Scholar
  42. 42.
    Crnich, C.J., Maki, D.G., (2001), The role of intravascular devices in sepsis. Curr. Infect. Dis. Rep. 3: 496 –506.PubMedGoogle Scholar
  43. 43.
    Crnich, C.J., Maki, D.G., (2005), Infections caused by intravascular devices: epidemiology, pathogenesis, diagnosis, prevention, and treatment. In: APIC text of Infection Control and Epidermiology. Vol. I, 2nd ed. Washington, DC: Association for Professionals in Infection Control and Epidemiology, pp. 2421–2426.Google Scholar
  44. 44.
    Pittet, D., Tarara, D., Wenzel, R.P., (1994), Nosocomial bloodstream infection in critically ill patients: Excess length of stay, extra costs, and attributable mortality. JAMA 271: 1598 – 1601.PubMedGoogle Scholar
  45. 45.
    Renaud, B., Brun-Bruisson, C., ICU-Bacteremia Study Group, (2001), Outcomes of primary and catheter-related bacteremia: a cohort and case control study in critically ill patients. Am. J. Respire. Crit. Care Med. 163: 1584 –1590.Google Scholar
  46. 46.
    Orsi, G.B., Di Stefano, C., Noah, N., (2002), Hospital acquired, laboratory confirmed bloodstream infections: increased length of stay and direct costs. Infect. Control Hosp. Epidemiol. 23: 190 –197.PubMedGoogle Scholar
  47. 47.
    Blot, S.I., Depuydt, P., Annemans, L., Benoit, D., Hoste, E., De Waele, J.J., Decruyenaere, J., Vogelaers, D., Colardyn, F., Vanderwoude, K.H., (2005), Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin. Infect. Dis. 41: 1591 –1598.PubMedGoogle Scholar
  48. 48.
    National Nosocomial Infection Surveillance, (2002), National nosocomial infection surveillance (NNIS) system report, data summary from January 1992 to June 2002, issued August 2002. Am. J. Infect. Control. 30: 458 –475.Google Scholar
  49. 49.
    Maki, d.G., Kluger, D.M., Crnich, C.J., (2006), The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin. Proc. 81: 1159 –1171.PubMedGoogle Scholar
  50. 50.
    Peters, G., Locci, R., Pulverer, G., (1982), Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters. J. Infect. Dis. 146: 479 –482.PubMedGoogle Scholar
  51. 51.
    Rupp, M.E., Ulphani, J.S., Fey, P.D., Bartscht, K., Mack, D., (1999), Characterization of the importance of polysaccharide intercellular, hemagglutinin of Staphylococcus epidermidis in the pathogenesis of biomaterial-based infection in a mouse foreign body infection model. Infect. Immun. 67: 2627 –2632.PubMedGoogle Scholar
  52. 52.
    Darouiche, R.O., (2001), Device-associated infections: A macroproblem that starts with microadherence. Clin. Infect Dis. 33: 1567 –1572.PubMedGoogle Scholar
  53. 53.
    Galdbart, J.-O., Allignet, J., Tung, H.-S., Ryden, C. E.L., Solh, N., (2000), Screening for Staphylococcus epidermidis markers discriminating between skin-flora strains and those responsible for infections of joint prosthesis. J. Infect. Dis. 182: 351 –355.PubMedGoogle Scholar
  54. 54.
    Vandescastede, S.J., Peetemans, W.E., Merckx, R., Van Eldere, J., (2003), Expression of biofilm-associated genes in Staphylococcus epidermidis during in vitro and in vivo foreign body infections. J. Infect. Dis. 188: 730 –737.Google Scholar
  55. 55.
    Wang, L., Li, M., Dong, D., Bach, T.-H.L., Sturdevant, D.E., Vuong, C., Otto, M., Gao, Q., (2008), SarZ is a key regulator of biofilm formation and virulence in Staphylococcus epidermidis J. Infect. Dis. 1971: 1254 –1262.Google Scholar
  56. 56.
    Darouiche, R.O., Landon, G.C., Patti, J.M., Nguyen, L.L., Fernau, R.C., Mc Devitt, D., Greene, C., Foster, T., Klima, M., (1997), Role of Staphylococcus aureus surface adhesions in orthopedic device infection. J. Med. Microbiol. 46: 75 –79.PubMedGoogle Scholar
  57. 57.
    Green, C., Mc Devitt, D., Francois, P., Vaudaux, P.E., Lew, D.P., Foster, T.J., (1995), Adhesion properties of mutants of Staphylococcus aureus defective in the fibronecting-binding proteins and studies on the expression of fnb genes. Mol. Microbiol. 17: 1143 –1145.Google Scholar
  58. 58.
    Matsaniotis, N.S., Syriopoulou, V.P., Theodoridou, M.C., Tzanetou, K.G., Mostrou, G.I., (1984), Enterobacter sepsis in infants and children due to contaminated intravenous fluid. Infect. Control 5: 471 –477.PubMedGoogle Scholar
  59. 59.
    Centers for Disease Control and Prevention, (1998), Enterobacter cloucae blood stream infections associated with contaminated prefilled saline syringes –California, November 1998. MMWR. Morb. Mortal. Wkly Rep. 47: 959 –960.Google Scholar
  60. 60.
    Maki, D.G., Rhame, F.S., Mackel, D.C., Bennett, J.V., (1976), Nationwide epidemic of septicemia caused by contaminated intravenous fluid. 1. Epidemiological and clinical features. Am. J. Med. 60: 471 –485.PubMedGoogle Scholar
  61. 61.
    Wang, S.A., Tokars, J.L., Bianchine, P.J., Carson, L.A., Arduino, M.J., Smith, A.L., Hansen, N.C., Fitzgerald, E.A., Epstein, J.S., Jarvis, W.R., (2000), Enterobacter cloacue bloodstream infections traced to contaminated human albumin. Clin. Infect. Dis. 30: 35 –40.PubMedGoogle Scholar
  62. 62.
    Brecher, M.E., Hay, S.N., (2005), Bacterial contamination of blood components. Clin. Microbiol. Rev. 18: 195 –204.PubMedGoogle Scholar
  63. 63.
    Rupp, M.E., Sholtz, L.A., Jourdan, D.R., Marion, N.D., Tyner, L.K., Fey, P.D., Iwen, P.C., Anderson, J.R., (2007), Outbreak of bloodstream infection temporally associated with the use of an intravascular needle-less valves. Clin. Infect. Dis. 44: 1408 –1414.PubMedGoogle Scholar
  64. 64.
    Raad, I., (1998), Intravascular-catheter-related infections. Lancet 351: 893 –898.PubMedGoogle Scholar
  65. 65.
    Kite, P., Dobbins, B.M., Wilcox, M.H., McMahon, M.J., (1999), Rapid diagnosis of central-venous – catheter-related bloodstream infection without catheter removal. Lancet 354: 1504 –1507.PubMedGoogle Scholar
  66. 66.
    Blot, F., Nitenberg, G., Chachaty, E., Raynard, B., Germann, N., Antoun, S., Laplanche, A., Brun-Buisson, C., Tancrède, C., (1999), Diagnosis of catheter-related bacteremia: a prospective comparison of the time to positively of hub-blood versus peripheral blood culture. Lancet 354: 1071 –1077.PubMedGoogle Scholar
  67. 67.
    Safdar, N., Fine, J.P., Maki, D.G., (2005), Meta-analysis: methods for diagnosing intravas-cular device-related blood stream infection. Ann. Intern. Med. 142: 451 –466.PubMedGoogle Scholar
  68. 68.
    Bouza, E., Alvarado, N., Alcala, L., Pérez, M.J., Ricon, C., Muñoz, P., (2007), A randomized and prospective study of 3 procedures for the diagnosis of catheter-related bloodstream infection without catheter withdrawal. Clin. Infect. Dis. 44: 820 –826.PubMedGoogle Scholar
  69. 69.
    Raad, T., Hanna, H.A., Alakech, B., Chatzinikolaou, I., Johnson, M.M., Tarrand, J., (2004), Differential time to positivity: a useful method for diagnosing catheter-related bloodstream infections. Ann. Intern. Med. 140: 18 –25.PubMedGoogle Scholar
  70. 70.
    Mermel, L.A., Farr, B.A., Sherertz, R.J., Raad, I.I., O'Grady, N., Harris, J.S., Craven, D.E., (2001), Guidelines for the management of intravascular catheter-related infections. Clin. Infect. Dis. 32: 1249 –1272.PubMedGoogle Scholar
  71. 71.
    Chastre, J., Wolff, M., Fagon, J.Y., Chevret, S., Thomas, F., Wermert, D., Clenenti, E., Gonzalez, J., Jusserand, D., Asfar, P., Perrin, D., Fieux, F., Aubas, S., Pneuma Trial Group, (2003), Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults. JAMA 290: 2588 –2598.PubMedGoogle Scholar
  72. 72.
    Bohnen, J.M., Solomkin, J.S., Dellinger, E.P., Bjornson, H.S., Page, C.P., (1992), Guidelines for clinical care: anti-infective agents for intra-abdominal infection. A surgical Infection Society Policy Statement. Arch. Surg. 127: 83 –89.PubMedGoogle Scholar
  73. 73.
    Manierski, C., Besarab, A., (2006), Antimicrobial locks: putting the lock on catheter infection. Adv. Chronic Kid. Dis. 13: 245 –258.Google Scholar
  74. 74.
    Messing, B., Peitra-Cohen, S., Debure, A., Beliah, M., Bernier, J.J., (1998), Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. J PEW J. Parenter. Enteral Nutr. 12: 185 –189.Google Scholar
  75. 75.
    Benoit, J.L., Carandang, G., Sitrin, M., Arnow, P., (1997), Intraluminal antibiotic treatment of central venous catheter infection in patients receiving parenteal nutrition at home. Clin. Infect. Dis. 24: 743 –744.PubMedGoogle Scholar
  76. 76.
    Krzywda, E.A., Andris, D.A., Edmiston, C.E. Jr, Quebbeman, E.J., (1995), Treatment of Hickman catheter sepsis using antibiotic-lock therapy. Infect. Control Hosp. Epidemiol. 16: 596 –598.PubMedGoogle Scholar
  77. 77.
    Cuntz, D., Michaud, L., Guimber, D., Husson, M.O., Gottrand, F., Turck, D., (2002), Local antibiotic-lock for the treatment of infection related to central catheters in parenteral nutrition in children. J PEN J. Parenter. Enteral. Nutr. 28: 104 –108.Google Scholar
  78. 78.
    Reimund, J.M., Arondel, Y., Finck, G., Zimmermann, F., Duclos, B., Baumann, R., (2002), Catheter-related infection in patients on home parenteral nutrition: Results of a prospective survey. Clin. Nutr. 21: 33 –38.PubMedGoogle Scholar
  79. 79.
    Capdevila, J.A., Segarra, A., Planes, A.M., Ramirez-Arellano, M., Pahissa, A., Piera, L., Martinez-Valzquez, J.M., (1993), Successful treatment of hemodialysis catheter-related sepsis without catheter removal. Nephrol. Dial. Transplant. 8: 231 –234.PubMedGoogle Scholar
  80. 80.
    Krishnasami, Z., Carlton, D., Bimbo, L., Taylor, M.E., Balkovetz, D.F., Barker, Allon, M., (2002), Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic-lock solution. Kidney Int. 61: 1136 –1142.PubMedGoogle Scholar
  81. 81.
    Poule, C.V., Carlton, D., Bimbo, L., Allon, M., (2004), Treatment of catheter-related bacteremia with an antibiotic-lock protocol: effect of bacterial pathogen. Nephrol. Dial. Transplant. 19: 1237 –1244.Google Scholar
  82. 82.
    Bernardi, M., Cavaliere, M., Cesaro, S., (2005), The antibiotic-lock therapy in oncohematol-ogy pediatric unit. Assist. Inferm. Ric. 24: 127 –131.PubMedGoogle Scholar
  83. 83.
    Sanchez-Muñoz, A., Aguado, J.M., Lopez-Martin, A, López-Medrano, F., Lumbreras, C., Rodriquez, F.J., Colomer, R, Lortes-Funes, F.J. (2005), Usefulness of antibiotic-lock technique in management of oncology patients with uncomplicated bacteremia related to tunnel catheters. Eur. J. Clin. Microbiol Infect. Dis. 24: 291 –293.PubMedGoogle Scholar
  84. 84.
    Manierski, C., Besarab, A., (2006), Antibiotic-locks: putting the lock on catheter infections. Adv. Chronic Kid. Dis. 13: 245 –258.Google Scholar
  85. 85.
    Fortún, F., Grill, F., Martin-Dávila, P., Blázquez, J., Tato, M., Sánchez-Corral, J., Garcia-San. Miguel, L., Moreno, S., (2006), Treatment of long-term intravascular catheter-related bacteremia with antibiotic-lock therapy. J. Antimicrob. Chemother. 58: 816 –821.PubMedGoogle Scholar
  86. 86.
    Ruhe, J.J., Menon, A., (2006), Clinical significance of isolated Staphylococcus aureus central venous catheter tip cultures. Clin. Microbiol. Infect. 12: 933 –936.PubMedGoogle Scholar
  87. 87.
    Ekkelonkamp, M.B., van der Bruggen, T., van der Vijven, D.A.M.C., Wolfs, T.F.W., Bonten, M.J.M., (2008), Bacteremic complications of intravascular catheters colonized with Staphylococcus aureus. Clin. Infect. Dis. 46: 114 –118.Google Scholar
  88. 88.
    McGee, D.C., Gould, M.K., (2003), Preventing complications of central venous catheteriza-tion. N. Engl. J. Med. 348: 1123 –1133.PubMedGoogle Scholar
  89. 89.
    Merrer, J., DeJonghe, B., Golliot. F., Lefrant, J.Y., Raffy, B., Barre, E., Rigaud, J.P., Casciani, D; Misset, B., Bosquet, C, Outin, H., Brun-Buisson, C, Nitenberg, G; French Catheter Study Group in Intensive Care (2001), Complications of femoral and subclavian venous catheterization in critically ill patients: A randomized controlled trial. JAMA 286: 700 –707.PubMedGoogle Scholar
  90. 90.
    McKinley, S., Mackenzie, A., Finfer, S., Ward, R., Penfold, J., (1999), Incidence and predictors of central venous catheter-related infection in intensive care patients. Anaesth. Intensive Care 27: 164 –169.PubMedGoogle Scholar
  91. 91.
    Raad, I, I., Hohn, D.C., Gilbreath, B.J., Suleiman, N., Hill, L.A., Bruso, P.A., Marts, K., Mansfield, P.F., Bodey, G.P., (1994), Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect. Control Hosp. Epidemiol. 15: 231 –238.PubMedGoogle Scholar
  92. 92.
    Maki, D.G., Ringer, M., Alvarado, C.J., (1991), Prospective randomized trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheter. Lancet 338: 339 –343.PubMedGoogle Scholar
  93. 93.
    Pronovost, P., Needham, D., Berenhotlz, S., Sinopoli, D., Chu, H., Cosgrove, S., Sexton, B., Hyzy, R., Welsh, R., Roth, G., Bander, J., Kepros, J., Goeschel, C., (2006), An intervention to decrease catheter-related bloodstream infections in the ICU. N. Engl. J. Med. 355: 2725 – 2732.PubMedGoogle Scholar
  94. 94.
    Wenzel, R.P., Edmond, M.B., (2006), Team-based prevention of catheter-related infections (editorial). N. Engl. J. Med. 355: 2781 –2783.PubMedGoogle Scholar
  95. 95.
    Raad, I.I., Hachem, R.Y., Abi-Said, D., Rolston, K.V., Whimbey E., Buzaid, A.C., Legha, S., (1998), A prospective cross-over randomized trial of novobiocin and rifampin prophylaxis for the prevention of intravascular catheter infections in cancer patients treated with inter-leukin -2. Cancer 82: 403 –411.PubMedGoogle Scholar
  96. 96.
    Henrickson, K.J., Astell, R.A., Hoover, S.M., Kuhn, S.M., Pritchett, J., Kehl, S.C., Klein, J. P., (2000), Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: a randomized, multicenter, double-blind trial. J. Clin. Oncol. 18: 1269 –1278.PubMedGoogle Scholar
  97. 97.
    Bock, S.N., Lee, R.E., Fisher, B., Rubin, J.T., Schwartzentruber, D.J., Wei, J.P., Callender, D.P., Yang, J.C., Lotze, M.T., Pizzo, P.A., (1990), A prospective randomized trial evaluating prophylactic antibiotics to prevent triple-lumen catheter-related sepsis in patients treated with immunotherapy. J. Clin. Oncol. 8: 161 –169.PubMedGoogle Scholar
  98. 98.
    Tacconelli, E., Carmeli, Y., Aizer, A., Ferreira, G., Foreman, M.G., D'Agata, E.M.C, (2003), Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. Clin. Infect. Dis. 37: 1629 –1638.PubMedGoogle Scholar
  99. 99.
    Bloom, B.S., Fendrick, A.M., Chernew, M.E., Patel, P., (1996), Clinical and economic effects of mupirocin calcium on preventing Stayphylococcus aureus infection in hemodialy-sis patients: a decision analysis. Am. J. Kidney Dis. 27: 687 –698.PubMedGoogle Scholar
  100. 100.
    Perez-Fontan, M., Rosales, M., Rodriguez-Carmona, A., Falcon, T.G., Valdes, F; (2002), Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis. Am. J. Kidney Dis. 39: 337 –341.PubMedGoogle Scholar
  101. 101.
    Levin, A., Mason, A.J., Jindal, K.K., Fong, I.W. Goldstein, M.B., (1991), Prevention of hemodialysis subclavian vein catheter infections by topical povidine-iodine. Kidney Internat. 40: 834 –938.Google Scholar
  102. 102.
    Veenstra, D.L., Saint, S., Saha, S., Lumley, T., Sulivan, S.D., (1999), Efficacy of antiseptic impregnated central venous catheters in preventing catheter-related bloodstream infection: A meta-analysis. JAMA 281: 261 –267.PubMedGoogle Scholar
  103. 103.
    Veenstra, D.L., Saint, S., Sullivan, S.D., (1999), Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection. JAMA 282: 554 –560.PubMedGoogle Scholar
  104. 104.
    Pearson, M.C., (1996), Guidelines for prevention of intravascular device-related infections. Hospital Infection Control Practices Advisory Committee. Infect. Control. Hosp. Epidemiol. 17: 391 –402.Google Scholar
  105. 105.
    McConnell, S.A., Gubbins, P.O., Anaissie, E.J., (2003), Do antimicrobial-impregnated central venous catheters prevent catheter-related bloodstream infection? Clin. Infect. Dis. 37: 65 –72.Google Scholar
  106. 106.
    Crnich, C.J., Maki, d.G., (2005), Are antimicrobial-impregnated catheters effective? When does repetition reach the point of exhaustion? Clin. Infect. Dis. 41: 681 –685.Google Scholar
  107. 107.
    Halpin, D.P., O'Byrne, P., McEntee, G., Hennessy, T.P., Stephens, R.B., (1991), Effect of a betadine connection shield on central venous catheter sepsis. Nutrition; 7: 33 –34.PubMedGoogle Scholar
  108. 108.
    Segura, M., Alvarez-Lerma, F., Tellado, J.M. Jim énez-Oms, L., Rello, J., Bar ó, T., Sanchez, R., Morera, A., Mariscal, D., Marrugat, J., Sitges-Serra, A., (1996), A clinical trial on the prevention of catheter-related sepsis using a new hub model. Ann Surg. 223: 363 –369.PubMedGoogle Scholar
  109. 109.
    Cabell, C.H., Heidenreich, P.A., Chu, V.H., Moore, C.M., Stryjewski, M.E., Corey., G.R., Fowler, V.G.Jr., (2004), Increasing rates of cardiac device infections among Medicare beneficiaries: 1990 –1999. Am. Heart J. 147: 582 –586.PubMedGoogle Scholar
  110. 110.
    Hill, E.E., Herijgers, P., Herregods, M.-C., Peetermans, W.E., (2006), Evolving trends in infective endocarditis. Clin. Microbiol. Infect. 12: 5 –12.PubMedGoogle Scholar
  111. 111.
    Devlin, R.K., Andrews, M.M., von Reyn, C.F., (2004), Recent trends in infective endocarditis: influence of case definitions. Curr. Opin. Cardiol. 19: 134 –139.PubMedGoogle Scholar
  112. 112.
    Moreillion, P., Que, Y.A., (2004), Infective endocarditis. Lancet; 363: 139 –149.Google Scholar
  113. 113.
    Wang, A., Athan, E., Pappas, P.A., Fowler, V.G., Olaison, L., Paré, C., Almirante, B., Muñoz, P., Logar, M., Tattevin, P., Iarussi, D.L., Selton-Suty, C., Jones, S.B., Casabé, J., Morris, A., Corey, G.R., Cabell, C.H., for the International Collaboration on Endocarditis-Prospective Cohort Study Investigators, (2007), Comtemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA 297: 1354 –1361.PubMedGoogle Scholar
  114. 114.
    Mylonakis, E., Calderwood, S.B., (2001), Infective endocarditis in adults. N. Engl. J. Med. 345: 1318 –1330.PubMedGoogle Scholar
  115. 115.
    Baddour, L.M., Wilson, W.R., Bayer, A.S., Fowler, V.G. Jr., Bolger, A.F., Levison, M.E., Ferrieri, P., Gerber, M.A., Tani, L.Y., Gewitz, M.H., Tong, D.C., Steckelberg, J.M., Baltimore, R.S., Shulman, S.T., Burns, J.C., Falace, D.A., Newburger, J.W., Pallasch, T.J., Takashashi, M., Taubert, K.A., (2005), Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association; endorsed by the Infectious Diseases Society of America. Circulation; 111: e394 –e434.PubMedGoogle Scholar
  116. 116.
    Horstkotte, D., Follath, F., Gutschik, E., Lengyet, M., Oto, A., Pavie, A., Soler-soler, J., Thienne, G., von Graeventitz: The Task Force on Infective Endocarditis of the European Society of Cardiology, (2004), Guidelines on prevention, diagnosis and treatment of infective endocarditis – executive summary. Eur. Heart. J. 25: 267 –276.PubMedGoogle Scholar
  117. 117.
    Malcolm, D.V.J., Hibberd, P.L., Karchmer, A.W., Sleeper, L.A., Calderwood, S.B., (1998), Staphylococcus aureus prosthetic valve endocarditis: Optimal management and risk factors for death. Clin. Infect. Dis. 26: 1302 –1309.Google Scholar
  118. 118.
    Chirouze, C., Cabell, C.H., Fowler, V.G. Jr., Khayat, N., Olaison, L., Miro, J.M., Habib, G, Abrutyn, E., Eykyn, S., Corey, G.R., Selton-Suty, C., Hoen, B, and the International Collaboration on Endocarditis Study Group, (2004), Prognostic factors in 61 cases of Staphylococcus aureus prosthetic valve infective endocarditis from the International Collaboration on endocarditis merged database. Clin. Infect. Dis. 38: 1323 –1327.PubMedGoogle Scholar
  119. 119.
    Vikram, H.R., Buenconsejo, J., Hasbun, R., Quagliarello, V.J., (2003), Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis. JAMA 290: 3207 –3214.PubMedGoogle Scholar
  120. 120.
    Wang, A., Pappas, P., Anstrom, K.J., Abrutyn, E., Fowler, V.G. Jr., Hoen, BN., Miro, J.M., Corey, G.R., Olaison, L., Stafford, J.A., Mestres, C.A., Cabell, C.H., and the International Collaboration on Endocarditis Investigators, (2005), The use and effect of surgical therapy for prosthetic valve endocarditis: A propensity analysis of a multicenter, international cohort. Am. Heart J. 150: 1086 –1091.PubMedGoogle Scholar
  121. 121.
    Akowuah, E.F., Davies, W., Oliver, S., Stephens, J., Riaz, I., Zadik, P., Cooper, G., (2003), Prosthetic valve endocarditis: early and late outcome following medical or surgical treatment. Heart 89: 269 –272.PubMedGoogle Scholar
  122. 122.
    Wilson, W., Taubert, K.A., Gewitz, M., Lockhart, P.B., Baddour, L.M., Levison, M., Bolger, A., Cabell, C.H., Takahashi, M., Baltimore, R.S., Newburger, J.W., Strom, B.L., Tani, L.Y., Gerber, M., Bonow, R.O., Pallasch, T., Shulman, S.T., Rowley, A.H., Burns, J.C., Ferrieri, P., Gardner, T., Goff, D., Durack, D.T., (2007), Prevention of infective endocarditis. Guidelines from the American Heart Association. A guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation; 115: http://circahajournals.org.
  123. 123.
    Grover, F.L., Cohen, D.J., Oprian, C., Henderson, W.G., Sethi, G, Hammermeister, K.E., Participants in the Department of Veterans Affair Cooperative Study in Valvular Heart Disease, (1994), Determinants of the occurrence of and survival from prosthetic valve endocarditis. Experience of the Veterans Affairs Cooperative Study on Valvular Heart Disease. Cardiovasc. Surg. 108: 207 –214.Google Scholar
  124. 124.
    Schaff, H.V., Carrel, T.P., Jamieson, W.R., Jones, K.W., Rufilanchas, J.J., Cooley, D.A., Hetzer, R., Stumpe, F., Duveau, D., Moseley, P., van Boven, W.J., Grunkemeir, G.L., Kennard, E.D., Holubkov, R., Artificial Valve Endocarditis Reduction Trial, (2002), Para-valvular leak and other events in silzone-coated mechanical heart valves: a report from AVERT. Ann. Thorac. Surg. 73: 785 –792.PubMedGoogle Scholar
  125. 125.
    Baddour, L.M., Bettman, M.A., Bolger, A.F., Epstein, A.E., Ferrieri, P., Gerber, M.A., Gewitz, M. H. Jacobs, A.K., Levison, ME., Newburger, J.W., Pallasch, T.J., Wilson, W.R., Baltimore, R.S., Falace, D.A., Shulman, S.T., Tani, L.Y., Taubert, K.A., (2003), Non-valvular cardiovascular device-related infections. Circulation 108: 2015 –2031.PubMedGoogle Scholar
  126. 126.
    Uslan, D.Z, Baddour, L.M., (2006), Cardiac device infection: Getting to the heart of the matter. Curr. Opin. Infect. Dis. 19: 345 –348.PubMedGoogle Scholar
  127. 127.
    Duval, X., Selton-Suty C., Alla, F., Salvador-Mazeng, M., Bernard, Y., Weber, M., Lacassin, F., Nazeyrolas, P., Chidac, C., Hoen, B, Leport, C., for the Association pour L 'Etude et la prevention de L'Endocarditis Infectieuse, (2004), Endocarditis in patients with a permanent pacemaker: a 1 – year epidemiological survey on infective endocarditis due to valvular and for pacemaker infection. Clin. Infect. Dis. 39: 68 –74.PubMedGoogle Scholar
  128. 128.
    Cohen, M.I., Bush, D.M., Gaynor, J.W., Vetter, V.L., Tanel, R.E., Rhodes, L.A., (2002), Pediatric pacemaker infection: Twenty years experience. J. Thorac. Cardiovasc. Surg. 124: 821 –827.PubMedGoogle Scholar
  129. 129.
    del Rio, A., Anguera, I., Miro, J.M., Mont, L., Fowler, V.G. Jr., Azqueta, M., Mestres, C.A., Hospital Clinic Endocarditis Group, (2003), Surgical treatment of pacemaker and defibrillator lead endocarditis: The impact of electrode lead extraction on outcome. Chest 124: 1451 – 1459.PubMedGoogle Scholar
  130. 130.
    Da Costa, A., Lelievre, H., Kirkorian, G., Celard, M., Chevalier, P., Vandenesch, F., Etienne, J., Touboul, P., (1998), Role of the preaxillary flora in pacemaker infections: A prospective study. Circulation 97: 1791 –1795.PubMedGoogle Scholar
  131. 131.
    Chamis, A.L., Peterson, G.E., Cabell, C.H., Corey, G.R., Sorrentino, R.A., Greenfield, R.A., Ryan, T, Rellar, L.B., Fowler, V.G.Jr., (2001), Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators. Circulation 104: 1029 –1033.PubMedGoogle Scholar
  132. 132.
    Klug, D., Wallet, F., Kacet, S., Courcol, R.J., (2005), Detailed bacteriologic tests to identify the origin of transvenous pacing system infections indicate a high prevalence of multiple organisms. Am. Heart J. 149: 322 –328.PubMedGoogle Scholar
  133. 133.
    Chau, J.D., Wilkoff, B.L. Lee, I., Juratli, N., Longworth, P.L., Gordon, S.M., (2000), Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann. Intern. Med. 133: 604 –608.Google Scholar
  134. 134.
    Cacoub, P., Leprince, P., Nataf, P., Hausfater, P., Dorent, R., Wechsler, B., Bors V., Pavie, A., Piette, J.C., Gandjbakhch, I., (1998), Pacemaker infective endocarditis. Am. J. Cardiol. 82: 480 –484.PubMedGoogle Scholar
  135. 135.
    Bracke. F.A., Meijer, A., van Gelder, L.M., (2001), Pacemaker lead complications: when is extraction appropriate and what can we learn from published data? Heart; 85: 254 –259.PubMedGoogle Scholar
  136. 136.
    Wilkoff, B.L., Byrd, C.L., Love, C.J., Hayes, D.L., Sellers, T.D., Schaerf, R., Parsonnet, V., Epstein, L.M., Sorrentino, R.A., Reiser, C., (1999), Pacemaker lead extraction with the laser sheath: results of the pacing lead extractions with the excimer sheath (PLEXES) trial J. Am. Coll. Cardiol. 33: 1671 –1676.Google Scholar
  137. 137.
    Ruttmann, E., Hangler, H.B., Kilo, J., Hofer, D., Muller, L.C., Hintringer, F., Muller, S., Laufer, G., Antretter, H., (2006), Transvenous pacemaker lead removal is safe and effective even in large vegetations: An analysis of 53 cases of pacemaker lead endocarditis. Pacing Clin. Electrophysiol. (PACE) 29: 231 –236.Google Scholar
  138. 138.
    Da Costa, A., Kirkorian, G., Cucherat, M., Delahaye, F., Chevalier, P., Cerisier, A., Isaaz, K., Touboul, P., (1998), Antibiotic prophylaxis for permanent pacemaker implantation. A meta-analysis. Circulation 97: 1796 –1801.PubMedGoogle Scholar
  139. 139.
    Sirvaratnam, K., Duggan, J.M., (2002), Left ventricular assist device infections: three cases and a review of the literature. ASAI OJ; 48: 2–7.Google Scholar
  140. 140.
    Hutchinson, O.Z., Oz, M.C., Ascherman, J.A., (2001), The use of muscle flaps to treat left ventricular assist device infections. Plastic Reconstrut. Surg. 107: 364 –373.Google Scholar
  141. 141.
    Malani, P.N., Dyke, D.B., Pagani, F.D., Chenoweth, C,E., (2002), Noscomial infections in left ventricular assist deivce recipients. Clin. Infect. Dis. 34: 1295 –1300.PubMedGoogle Scholar
  142. 142.
    Mekontso-Dessap, A., Kirsch, M., Vermes, E., Brun-Buisson, C., Loisance, D., Houël, R., (2002), Nosocomial infections occurring during receipt of circulatory support with para-corporal ventricular assist system. Clin. Infect. Dis. 35: 1308 –1315.PubMedGoogle Scholar
  143. 143.
    Rose, E.A., Gelijns, A.C., Moskowitz, A.J., Heitjan, D.F., Stevenson, L.W., Dembitsky, W., Long, J.W., Ascheim, D.D., Tierney, A.R., Levitan, R.G., Watson, J.T., Meier, P., for the Randomized Evaluation of Mechanical Assistance for the treatment of Congestive Heart Failure (Rematch) Study Group, (2001), Long-term use of a left ventricular assist device for end-stage heart failure. N. Engl. J. Med. 345: 1435 –1443.PubMedGoogle Scholar
  144. 144.
    Miller, L.W., Pagani, F.D., Russell, S.D., John, R., Boyle, A.J., Aaronson, K.D., Conte, J.V., Naka, Y., Mancini, D., Delgado, R.M., MacGillivray, Farrar, D.J., Frazier, O.H., for the Heart Mate II Clinical Investigators, (2007), Use of a continuous-flow device in patients awaiting heart transplantation. N. Eng. J. Med. 357: 885 –896.Google Scholar
  145. 145.
    Holman, W.L., Rayburn, B.K., McGiffin, D.C., Foley, B.A., Benza, R.L., Bourge, R.C., Pinderski, L.J., Kirklin, J.K., (2003), Infection in ventricular assist devices: prevention and treatment. Ann. Thorac. Surg. 75 (Suppl): s48 –s57.PubMedGoogle Scholar
  146. 146.
    Pasque, M.K., Hanselman, T., Shelton, K., Kehoe-Huck, B.A., Hedges, R., Cussivi, S.D., Ewald, G.A., Rogers, J.G., (2002), Surgical management of Novacor drive-line exit site infections. Ann. Thorac. Surg. 74: 1267 –1268.PubMedGoogle Scholar
  147. 147.
    Saijjadian, A., Valero, I.L., Acurturk, O., Askari, M.A., Sacks, J., Kormos, R.L., Manders, E. K., (2006), Omental transposition flap for salvage of ventricular assist devices. Plast. Reconstr. Surg. 118: 919 –926.Google Scholar
  148. 148.
    Darouiche, R.O., (2004), Treatment of infections associated with surgical implants. N. Engl. J. Med. 340: 1422 –1429.Google Scholar
  149. 149.
    P.H., Brinkman, W.T., Terramani, T.T., Lumsden, A.B., (2002), Management of Infected hemodialysis access grafts using cryopreserved human vein allografts. Am. J. Surg. 184: 31 –36.Google Scholar
  150. 150.
    Schutte, W.P., Helmer, S.D., Salazar, L., Smith, J.L., (2007), Surgical treatment of infected prosthetic dialysis arteiovenous grafts: Total versus partial graft excision. Am. J. Surg. 193: 385 –388.PubMedGoogle Scholar
  151. 151.
    Chiesa, R., Astore, D., Piccolo, G., Melissano, G., Jannello, A., Frigerio, D., Agrifoglio, G., Bonalumi, F., Corsi, G., Costantini Brancadoro, S., Novali, C., Locati, P., Odero, A., Pirrelli, S., Cugnasca, M., Biglioli, P., Sala, A., Polvani, G., Guarino, A., Biasi, GM., Mingazzini, P., Scalamogna, M., Mantero, S., Spina, G., Prestipino, F., et al., (1998), Fresh and cryopre-served arterial homografts in the treatment of prosthetic graft infections: experience of the Italian Collaboration Vascular Homograft Group. Ann. Vasc. Surg. 121: 457 –462.Google Scholar
  152. 152.
    Illuminati, G., Calio, F.G., D'Urso, A., Giacobbi, D., Papaspyropoulos, V., Ceccanei, G., (2004), Infrascrotal, perineal, femorofemoral bypass for arterial graft infection at the groin. Arch. Surg. 139: 1314 –1319.Google Scholar
  153. 153.
    Seify, H., Moyer, H.R., Jones, G.E., Busquets, A., Brown, K., Salam, A., Losken, A., Culbertson, J., Hester, T.R., (2006), The role of muscle flaps in wound salvage after vascular graft infections: The Emory experience. Plast. Reconstr. Surg. 117: 1325 –1333.PubMedGoogle Scholar
  154. 154.
    Graham, R.G., Omotoso, P.O., Hudson, D.A., (2002), The effectiveness of muscle flaps for the treatment of prosthetic graft sepsis. Plast. Reconstr. Surg. 109: 108 –113.PubMedGoogle Scholar
  155. 155.
    Chambers, S.T., (2005), Diagnosis and management of staphylococcal infections of vascular grafts and stents. Intern. Med. J. 35 (Suppl 2): s72 –s78.PubMedGoogle Scholar
  156. 156.
    Annovazzi, A., Bagni, B., Burroni, L., D'Alessandrla, C. Signore, A., (2005), Nuclear Medicine imaging of inflammatory infective disorders of the abdomen. Nucl. Med. Com-mun. 26: 657 –664.Google Scholar
  157. 157.
    Chiesa, R., Astore, D., Frigerio, S., Garriboli. L., Piccolo, G., Castellano, R., Scalamogna, M., Odero, A., Pirrelli, S., Biasi, G., Mingazzini, P., Biglioli, P., Poloani, g., Guarino, A., Agrifoglio, G., Tori, A., Spina, G., (2002), Vascular prosthetic graft infection: Epidermiology, bacteriology, pathogenesis and treatment. Actu Chirugica Belgica 102: 238 –247.Google Scholar
  158. 158.
    O 'Connor, S., Andrew, P., Batt, M., Becquemin, J.P., (2006), A systematic review and meta-analysis of treatments for aortic graft infection. J. Vasc. Surg. 44: 38 –45.PubMedGoogle Scholar
  159. 159.
    Calligaro, K.D., Veith, F.J., Yuan, J.G., Gargiulo, N.J., Dougherty, M.J., (2003), Intra-abdominal aortic graft infection: complete or partial graft preservation in patients at very high risk. J. Vasc. Surg. 38: 1199 –1205.PubMedGoogle Scholar
  160. 160.
    Mitra, A., Spears, J., Perrotta, V., McClurkin, J., Mitra, A., (2005), Salvage of infected prosthetic grafts of the great vessels via muscle flaps reconstruction. Chest 128: 1040 –1043.PubMedGoogle Scholar
  161. 161.
    Fiorani, P., Speziale, F., Calisti, A., Misuraca, M., Zaccagnini, D., Rizzo, L., Giannoni, M.F., (2003), Endovascular graft infection: preliminary results of an international enquiry. J. Endovasc. Therapy 10: 919 –927.Google Scholar
  162. 162.
    L'Heureux, N., Dusserre, N., Konig, G., Victor, B., Keire, P., Wight, T.N., Chronos, N.A., Kyles, A.E., Gregory, C.R., Hoyt, G., Robbins, R.C., McAllister, T.N., (2006), Human tissue-engineered blood vessels for adult revascularization. Nat. Med. 12: 361 –365.PubMedGoogle Scholar
  163. 163.
    L'Heureux, N., McAllister, T.N., de La Fuente, L.M., (2007), Tissue-engineered blood vessel for adult arterial revascularization. N. Engl. J. Med. 357: 1451 –1453.PubMedGoogle Scholar
  164. 164.
    Hentzer, M., Givskor, M., (2003), Pharmacological inhibition of quorum sensing for the treatment of chronic bacterial infections. J. Clin. Invest. 112: 1300 –1307.PubMedGoogle Scholar
  165. 164.
    Kwakman, P.H., te Velde, A.A., Vandenbroucke-Grauls, C.M., van Deventer, S.J., Zaat, S. A., (2006), Treatment and prevention of Staphylococcus epidermidis experimental biomaterial-associated infection by bactericidal peptide 2. Antimicrob. Agents Chemother. 50: 3977 –3983.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Personalised recommendations